Invention Grant
- Patent Title: Methods of hormonal treatment utilizing ascending-dose extended cycle regimens
- Patent Title (中): 使用升剂量延长周期治疗的激素治疗方法
-
Application No.: US11892026Application Date: 2007-08-17
-
Publication No.: US08415332B2Publication Date: 2013-04-09
- Inventor: Charles E. Diliberti , Kathleen Z. Reape , Lance J. Bronnenkant
- Applicant: Charles E. Diliberti , Kathleen Z. Reape , Lance J. Bronnenkant
- Applicant Address: US NJ Woodcliff Lake
- Assignee: Teva Woman's Health, Inc.
- Current Assignee: Teva Woman's Health, Inc.
- Current Assignee Address: US NJ Woodcliff Lake
- Agency: Sterne, Kessler, Goldstein & Fox P.L.L.C.
- Main IPC: A61K31/56
- IPC: A61K31/56
Abstract:
The present invention provides ascending-dose extended cycle regimens in which a female is administered an estrogen and a progestin for a period of greater than 30 or 31 consecutive days, optionally followed by a hormone-free period or by a period of administration of estrogen. The disclosed regimens can be administered to a female to provide contraceptive and non-contraceptive benefits.
Public/Granted literature
- US20080125402A1 Methods of hormonal treatment utilizing ascending-dose extended cycle regimens Public/Granted day:2008-05-29
Information query
